Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2004
10/13/2004EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004EP1465996A2 Raf/ras binding compounds
10/13/2004EP1465994A2 Rabbit nuclear cloning method and uses thereof
10/13/2004EP1465989A1 Growth factor modified protein matrices for tissue engineering
10/13/2004EP1465985A2 High level cytokine production with enhanced cell viability
10/13/2004EP1465927A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
10/13/2004EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004EP1465923A1 Corticotropin releasing factor receptor 2 agonists
10/13/2004EP1465922A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004EP1465921A2 Corticotropin releasing factor receptor 2 agonists
10/13/2004EP1465920A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy
10/13/2004EP1465919A2 Insect g protein-coupled receptor genes and uses thereof
10/13/2004EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004EP1465912A2 Novel chimeric tnf ligands
10/13/2004EP1465909A2 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
10/13/2004EP1465908A2 Compositions and methods for hydroxylating epothilones
10/13/2004EP1465907A2 Modular peptide-based reagent
10/13/2004EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004EP1465847A1 Highly homogeneous serum albumin as chiral selector
10/13/2004EP1465670A2 Labeling targeting agents with gallium-68 and gallium-67
10/13/2004EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004EP1465651A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
10/13/2004EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
10/13/2004EP1465489A2 Methods of expressing lim mineralization protein in non-osseous cells
10/13/2004EP1280820B1 Anti-inflammatory compounds and uses thereof
10/13/2004EP1203014B1 Peptide antagonists of factor viia
10/13/2004EP1179095A4 Methods for producing modified nucleic acid molecules
10/13/2004EP1154786B1 Compositions for altering mucus secretion
10/13/2004EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction
10/13/2004EP1062230B1 Method for increasing the serum half-life of a biologically active molecule
10/13/2004EP1029042A4 A ph sensitive potassium channel in spermatocytes
10/13/2004EP1023450A4 Bacterial resistance in grapevine
10/13/2004EP1012291B1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
10/13/2004EP1007970B1 Diagnostic kit for skin tests, and method
10/13/2004EP0968309B1 Method for determining a nucleic acid
10/13/2004EP0959894B1 Use of substrate subtraction libraries to distinguish enzyme specificities
10/13/2004EP0937155B1 Resistance against nematodes and/or aphids
10/13/2004EP0918851B1 Expression system for altered expression levels
10/13/2004EP0876402B1 Growth hormone secretagogue receptor family
10/13/2004EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases
10/13/2004EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
10/13/2004EP0817847B1 Il-17 receptor
10/13/2004EP0739353B1 Bacterial receptor structures
10/13/2004EP0736096B1 Antimicrobial proteins
10/13/2004EP0719147B1 Gene therapy for solid tumors, papillomas and warts
10/13/2004EP0688361B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/13/2004EP0666915B1 The pct-65 serotonin receptor
10/13/2004EP0652975B1 Assessment of trans-acting factors allelic variation
10/13/2004EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
10/13/2004CN1537164A Compositions and methods for therapy and diagnosis of Her-2/neu associated malignancies
10/13/2004CN1537162A Attenuated circovirus
10/13/2004CN1537161A Antigen presenting cells, method for their preparation and their use for cancer vaccines
10/13/2004CN1537117A 干扰素γ多肽变体 IFN-γ polypeptide variant
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1536965A Gelling vegetable protein
10/13/2004CN1536089A Promotor for expressing gene in fungal cell
10/13/2004CN1536082A Coding gene of hirudin mutant and high-effective expression strain
10/13/2004CN1536081A Gene related to function of skeletal muscle and cardiac muscle and its coded protein
10/13/2004CN1535986A Blood substitute prepared by using hematoglobin-human seralbumin conjugate and its preparation method
10/13/2004CN1535984A Human liver regeneration promoting factor and its expression
10/13/2004CN1535983A Blood vessel generating inhibitor
10/13/2004CN1535982A Na+/H+ retrograde transport protein of New Zedland spinach, its coding gene and application
10/13/2004CN1535981A Peptide capable of lyzing pathogen and its application
10/13/2004CN1535723A Extraction and application of cell growth promoting peptid orjgenated from silk protein
10/13/2004CN1535722A Colostrum peptide and its application
10/13/2004CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same
10/13/2004CN1170940C Plant with modified growth and method for obtained said plant
10/13/2004CN1170936C Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities
10/13/2004CN1170934C Proteins derived from white spot syndrome virus and uses thereof
10/13/2004CN1170933C Motilin homologs
10/13/2004CN1170932C Method for producing a peptide with a PI above 8 or below 5
10/13/2004CN1170931C Vasculogenesis correlation molecule
10/13/2004CN1170929C Human protein able to suppress growth of cancer cells and its coding sequence
10/13/2004CN1170927C Method for producing medicine using silkworm expressed numan epidermal growth factor
10/13/2004CN1170851C Fatty diacylamino acid insulin as oral medicine for treating diabetes and its synthesizing process
10/13/2004CN1170850C Human angiogenin-like protein and coding sequence and application thereof
10/13/2004CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004CN1170848C Novel human hepatoma associated protein and coding sequence thereof
10/13/2004CN1170847C Giant-web bominator antimicrobial peptide and its prepn and gene
10/13/2004CN1170846C Giant-web bominator angiectasis factor and its prepn and gene
10/13/2004CN1170845C Giant-web bombinator antineoplastic protein and its prepn and gene
10/13/2004CN1170844C Human macrobiosis-ensuring protein and its coding sequence and application
10/13/2004CN1170843C Novel huamn protein with function of promoting growth of cancer cell and its code sequence
10/13/2004CN1170840C Method for transforming plant from monocyclic flower to polycyclic flower
10/13/2004CN1170839C Method for making plant seedling leaf albino death
10/13/2004CN1170838C Specific gene associated with stunt of arabidopsis
10/13/2004CN1170837C Specific gene for controlling thickness of moaseearcress' stem
10/13/2004CN1170594C 弯曲菌疫苗 Campylobacter vaccine
10/13/2004CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors
10/13/2004CN1170587C I (Robinia Pseudoacacia) lectin and its uses
10/12/2004US6804611 Apparatus and method for automated protein design
10/12/2004US6803500 Used to control morning glory color
10/12/2004US6803499 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
10/12/2004US6803497 By identifying a diagnostic fragment; for agrifood industries; used to create hybrid plants
10/12/2004US6803454 Method for extraction and purification of cartilage type proteoglycan
10/12/2004US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004US6803452 RPTP-β antibodies
10/12/2004US6803451 Comprises nucleotide sequences coding transmembrane polypeptide for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells; drug screening
10/12/2004US6803450 Fusion protein; genetic engineering; energy storage
10/12/2004US6803449 Polypeptide for use in the diagnosis and treatment viral diseases